These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32394638)

  • 1. NIR light-triggered nanomaterials-based prodrug activation towards cancer therapy.
    Zhang F; Wu Q; Liu H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1643. PubMed ID: 32394638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-infrared light-responsive nanomaterials for cancer theranostics.
    Kim H; Chung K; Lee S; Kim DH; Lee H
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):23-45. PubMed ID: 25903643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in near infrared light responsive multi-functional nanostructures for phototheranostic applications.
    Thangudu S; Kaur N; Korupalli C; Sharma V; Kalluru P; Vankayala R
    Biomater Sci; 2021 Aug; 9(16):5472-5483. PubMed ID: 34269365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging Strategies in Stimuli-Responsive Prodrug Nanosystems for Cancer Therapy.
    Ding C; Chen C; Zeng X; Chen H; Zhao Y
    ACS Nano; 2022 Sep; 16(9):13513-13553. PubMed ID: 36048467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells.
    Braga CB; Perli G; Becher TB; Ornelas C
    Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-Infrared-Light-Activatable Nanomaterial-Mediated Phototheranostic Nanomedicines: An Emerging Paradigm for Cancer Treatment.
    Vankayala R; Hwang KC
    Adv Mater; 2018 Jun; 30(23):e1706320. PubMed ID: 29577458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-infrared light-triggered nano-prodrug for cancer gas therapy.
    Liu R; Peng Y; Lu L; Peng S; Chen T; Zhan M
    J Nanobiotechnology; 2021 Dec; 19(1):443. PubMed ID: 34949202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semiconducting Polymer Nanomaterials as Near-Infrared Photoactivatable Protherapeutics for Cancer.
    Li J; Pu K
    Acc Chem Res; 2020 Apr; 53(4):752-762. PubMed ID: 32027481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimeric prodrug-based nanomedicines for cancer therapy.
    Li S; Shan X; Wang Y; Chen Q; Sun J; He Z; Sun B; Luo C
    J Control Release; 2020 Oct; 326():510-522. PubMed ID: 32721523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent near-infrared light-activated nanomedicine toward precision cancer therapy.
    Luan X; Pan Y; Gao Y; Song Y
    J Mater Chem B; 2021 Sep; 9(35):7076-7099. PubMed ID: 34124735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in situ tracking cancer chemotherapy by highly photostable NIR fluorescent theranostic prodrug.
    Wu X; Sun X; Guo Z; Tang J; Shen Y; James TD; Tian H; Zhu W
    J Am Chem Soc; 2014 Mar; 136(9):3579-88. PubMed ID: 24524232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy and nanomedicine: Drug mechanisms and delivery systems.
    Molinaro M; Skrodzki D; Pan D
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1984. PubMed ID: 39109509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimuli-responsive prodrug-based cancer nanomedicine.
    Xie A; Hanif S; Ouyang J; Tang Z; Kong N; Kim NY; Qi B; Patel D; Shi B; Tao W
    EBioMedicine; 2020 Jun; 56():102821. PubMed ID: 32505922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine and drug delivery systems in cancer and regenerative medicine.
    Garbayo E; Pascual-Gil S; Rodríguez-Nogales C; Saludas L; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1637. PubMed ID: 32351045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular nanomedicines through rational design of self-assembling prodrugs.
    Wang H; Monroe M; Leslie F; Flexner C; Cui H
    Trends Pharmacol Sci; 2022 Jun; 43(6):510-521. PubMed ID: 35459589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Block copolymer prodrugs: Synthesis, self-assembly, and applications for cancer therapy.
    Dutta D; Ke W; Xi L; Yin W; Zhou M; Ge Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1585. PubMed ID: 31452353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advancements in two-dimensional nanomaterials for drug delivery.
    Mei X; Hu T; Wang Y; Weng X; Liang R; Wei M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1596. PubMed ID: 31650709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional nanomaterials for near-infrared-triggered cancer therapy.
    Liu B; Li C; Cheng Z; Hou Z; Huang S; Lin J
    Biomater Sci; 2016 Jun; 4(6):890-909. PubMed ID: 26971704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxanes prodrug-based nanomedicines for cancer therapy.
    Sun L; Zhao P; Chen M; Leng J; Luan Y; Du B; Yang J; Yang Y; Rong R
    J Control Release; 2022 Aug; 348():672-691. PubMed ID: 35691501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.